An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: Limitations of its use

Annals of the Rheumatic Diseases

Volumn 59, Issue 6, 2000, Pages 487-489

  Morton, S J ^a   Powell, R J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ACTIVITY; DISEASE DURATION; DOSE RESPONSE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HIRSUTISM; HUMAN; HYPERTENSION; MALE; MIXED CONNECTIVE TISSUE DISEASE; MYALGIA; NEPHROTOXICITY; PRIORITY JOURNAL; REMISSION; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT INDICATION;

ADULT; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES;

EID: 0034094430     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.6.487     Document Type: Article

References (11)

1. 1 Isenberg DA, Snaith ML, Morrow WJW, Al-khader AA, Cohen SL, Fisher C. Cyclosporin A for the treatment of systemic lupus erythematosus. Int J Immunopharmacol 1981;3:163-9.
2. 2 Feutren G, Querin S, Noel H, Chatenoud L, Beaurain G, Tron F, et al. Effects of cyclosporine in severe systemic lupus erythematosus. J Pediatr 1987;111:1063-8.
3. 3 Favre H, Miescher PA, Huang YP, Chatelanat F, Mihatsch MJ. Cyclosporin in the treatment of lupus nephritis. Am J Nephrol 1989; 9(suppl 1):57-60.
4. 4 Tokuda M, Kurata N, Mizoguchi A, Masayuki I, Seto K, Kinashi M, et al. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum 1994;37:551-8.
5. 5 Miescher PA, Favre H, Lemoine R, Huang Y-P. Drug combination therapy of systemic lupus erythematosus. Springer Semin Immunopathol 1994;16:295-311.
6. 6 Manger K, Kalden JR, Manger B. Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study. Br J Rheumatol 1996;35:669-75.
7. 7 Caccavo D, Lagana B, Mitterhofer AP, Ferri GM, Afeltra A, Amoroso A, et al. Long-term treatment of systemic lupus erythematosus with cyclosporin A. Arthritis Rheum 1997; 40:27-35.
8. 8 Dostal C, Tesar V, Rychlik I, Zabka J, Vencovsky J, Bartunkova J, et al. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study. Lupus 1998;7:29-36.
9. 9 Tan EM, Cohen AS, Fries JF, Masi A, McShane D, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
10. 10 Sugiyama M, Ogasawara H, Kaneko H, Hishikawa T, Iida N, Hashimoto H, et al. Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus. Lupus 1998;7:53-6.
11. 11 Sekigawa I, Ogawawara H, Sugiyama M, Kaneko H, Hishikawa T, Tokano Y, et al. Extremely low dose treatment of cyclosporine for autoimmune diseases [letter]. Clin Exp Rheumatol 1998;16:352.